164 related articles for article (PubMed ID: 9135388)
1. Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management.
Boulton M; Gregor Z; McLeod D; Charteris D; Jarvis-Evans J; Moriarty P; Khaliq A; Foreman D; Allamby D; Bardsley B
Br J Ophthalmol; 1997 Mar; 81(3):228-33. PubMed ID: 9135388
[TBL] [Abstract][Full Text] [Related]
2. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
[TBL] [Abstract][Full Text] [Related]
3. Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown.
Pfeiffer A; Spranger J; Meyer-Schwickerath R; Schatz H
Diabetes; 1997 Sep; 46 Suppl 2():S26-30. PubMed ID: 9285495
[TBL] [Abstract][Full Text] [Related]
4. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study.
Burgos R; Mateo C; Cantón A; Hernández C; Mesa J; Simó R
Diabetes Care; 2000 Jan; 23(1):80-3. PubMed ID: 10857973
[TBL] [Abstract][Full Text] [Related]
5. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.
Simó R; Hernández C; Segura RM; García-Arumí J; Sararols L; Burgos R; Cantón A; Mesa J
Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the circulating IGF system and the presence of retinopathy in Type 1 diabetic patients.
Frystyk J; Bek T; Flyvbjerg A; Skjaerbaek C; Ørskov H
Diabet Med; 2003 Apr; 20(4):269-76. PubMed ID: 12675639
[TBL] [Abstract][Full Text] [Related]
7. Deficient activation and different expression of transforming growth factor-beta isoforms in active proliferative diabetic retinopathy and neovascular eye disease.
Spranger J; Meyer-Schwickerath R; Klein M; Schatz H; Pfeiffer A
Exp Clin Endocrinol Diabetes; 1999; 107(1):21-8. PubMed ID: 10077351
[TBL] [Abstract][Full Text] [Related]
8. Changes in vitreous concentrations of human hepatocyte growth factor (hHGF) in proliferative diabetic retinopathy: implications for intraocular hHGF production.
Nishimura M; Ikeda T; Ushiyama M; Kinoshita S; Yoshimura M
Clin Sci (Lond); 2000 Jan; 98(1):9-14. PubMed ID: 10600653
[TBL] [Abstract][Full Text] [Related]
9. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy.
Spranger J; Bühnen J; Jansen V; Krieg M; Meyer-Schwickerath R; Blum WF; Schatz H; Pfeiffer AF
Horm Metab Res; 2000 May; 32(5):196-200. PubMed ID: 10871161
[TBL] [Abstract][Full Text] [Related]
10. Vitreous polyamines spermidine, putrescine, and spermine in human proliferative disorders of the retina.
Nicoletti R; Venza I; Ceci G; Visalli M; Teti D; Reibaldi A
Br J Ophthalmol; 2003 Aug; 87(8):1038-42. PubMed ID: 12881351
[TBL] [Abstract][Full Text] [Related]
11. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy.
George B; Chen S; Chaudhary V; Gonder J; Chakrabarti S
Curr Eye Res; 2009 Feb; 34(2):134-44. PubMed ID: 19219685
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
13. The effect of scatter laser photocoagulation on intravitreal levels of growth factors in the miniature pig.
Xiao M; Khaliq A; Moriarty P; McLeod D; Cranley J; Boulton M
Curr Eye Res; 1996 Sep; 15(9):923-31. PubMed ID: 8921212
[TBL] [Abstract][Full Text] [Related]
14. Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatment.
Al Kahtani E; Xu Z; Al Rashaed S; Wu L; Mahale A; Tian J; Abboud EB; Ghazi NG; Kozak I; Gupta V; Arevalo JF; Duh EJ
Eye (Lond); 2017 Apr; 31(4):529-536. PubMed ID: 27886182
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization.
Grant M; Russell B; Fitzgerald C; Merimee TJ
Diabetes; 1986 Apr; 35(4):416-20. PubMed ID: 2420665
[TBL] [Abstract][Full Text] [Related]
16. Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab.
Li JK; Wei F; Jin XH; Dai YM; Cui HS; Li YM
Int J Ophthalmol; 2015; 8(6):1202-6. PubMed ID: 26682173
[TBL] [Abstract][Full Text] [Related]
17. Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?
Spranger J; Möhlig M; Osterhoff M; Bühnen J; Blum WF; Pfeiffer AF
Horm Metab Res; 2001 May; 33(5):312-6. PubMed ID: 11440279
[TBL] [Abstract][Full Text] [Related]
18. Vitreal insulin-like growth factor binding proteins (IGFBPs) are increased in human and animal diabetics.
Waldbillig RJ; Jones BE; Schoen TJ; Moshayedi P; Heidersbach S; Bitar MS; van Kuijk FJ; de Juan E; Kador P; Chader GJ
Curr Eye Res; 1994 Jul; 13(7):539-46. PubMed ID: 7523030
[TBL] [Abstract][Full Text] [Related]
19. Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment.
Tuuminen R; Sahanne S; Loukovaara S
Acta Ophthalmol; 2014 Nov; 92(7):675-81. PubMed ID: 24506800
[TBL] [Abstract][Full Text] [Related]
20. Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid.
Asaria RH; Kon CH; Bunce C; Sethi CS; Limb GA; Khaw PT; Aylward GW; Charteris DG
Br J Ophthalmol; 2004 Nov; 88(11):1439-42. PubMed ID: 15489490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
